NBIX
Neurocrine Biosciences Inc
138.90$
-0.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| -5.2% | -5.0% | -10.6% | -12.5% | -15.1% | 53.9% | 657.0% | 139.6% | 153.1% | 112.1% | 337.7% | 8,428.3% | 1,657.1% | 1,519.8% | 128.3% | 53.9% | 21.8% | 472.8% | – | 171.0% | 239.3% | 0.8% | 1.1% | 0.9% | 1.0% | 1.3% | 1.6% | 2.1% | 1.4% | 1.8% | |
| 105.2% | 105.0% | 110.6% | 112.5% | 115.1% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 78.2% | -372.8% | – | 100.0% | 100.0% | 99.2% | 98.9% | 99.1% | 99.0% | 98.7% | 98.4% | 97.9% | 98.6% | 98.2% | |
| 65.6% | 76.2% | 136.3% | 173.8% | 275.8% | 180.1% | 603.7% | 127.5% | 135.1% | 86.1% | 249.0% | 6,698.1% | 1,397.3% | 1,142.0% | 93.0% | 40.0% | 69.9% | 1,344.6% | – | 412.2% | 628.6% | 56.8% | 35.6% | 25.4% | 26.3% | 28.9% | 31.2% | 29.9% | 31.0% | 35.5% | |
| 19.3% | 21.8% | 41.3% | 44.6% | 68.3% | 26.3% | 70.5% | 14.8% | 26.4% | 34.2% | 139.9% | 3,062.2% | 509.2% | 502.2% | 48.0% | 16.2% | 25.3% | 457.3% | – | 164.3% | 453.9% | 105.1% | 55.2% | 44.9% | 41.4% | 51.5% | 50.6% | 45.1% | 34.7% | 40.4% | |
| 90.1% | 103.1% | 188.1% | 231.0% | 359.1% | 206.4% | 674.2% | 142.3% | 161.4% | 120.2% | 388.8% | 17,440.0% | 2,296.2% | 1,917.5% | 141.0% | 56.2% | 97.3% | 1,801.9% | – | 576.5% | 1,082.5% | 180.5% | 90.7% | 89.9% | 83.4% | 89.7% | 81.7% | 84.6% | 74.3% | 76.5% | |
| 15.1% | 1.9% | -77.5% | -118.5% | -244.0% | -106.4% | -574.2% | -42.3% | -61.4% | -20.2% | -288.8% | -17,340.0% | -2,196.2% | -1,817.5% | -41.0% | 43.8% | 2.7% | -1,701.9% | – | -476.5% | -982.5% | -81.3% | 8.2% | 9.2% | 15.6% | 9.0% | 16.7% | 13.3% | 24.2% | 21.6% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.7% | 0.4% | 2.3% | 3.4% | 9.5% | 320.5% | 176.7% | 237.9% | 21.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | 0.0% | 12.1% | 6.8% | 4.1% | 3.1% | 2.3% | 0.5% | 0.2% | 5.4% | – | |
| 31.8% | 20.3% | -123.8% | -117.3% | -195.4% | -89.2% | -523.9% | -21.6% | -53.6% | -17.9% | -273.2% | -16,936.2% | -2,229.3% | -3,000.8% | -23.8% | 48.5% | 9.5% | -1,579.0% | – | -449.8% | -940.6% | -88.2% | 4.8% | 5.9% | 10.2% | 8.9% | 14.4% | 17.6% | 20.6% | 24.7% | |
| 1.0% | 0.8% | 47.5% | -18.5% | 2.1% | 0.3% | -50.3% | 0.1% | 0.1% | – | – | -403.8% | 33.1% | 5.9% | – | -5.5% | -7.9% | -145.4% | – | -31.7% | -51.5% | 10.6% | 0.2% | 1.2% | -28.7% | 1.0% | 4.0% | 4.4% | 6.1% | 7.9% | |
| 30.7% | 19.5% | -125.0% | -100.0% | -197.5% | -89.5% | -523.9% | -21.8% | -53.7% | -17.9% | -273.2% | -16,936.2% | -2,229.3% | -1,728.3% | -23.8% | 48.5% | 9.5% | -1,579.0% | – | -449.8% | -940.6% | -88.2% | 4.7% | 4.7% | 38.9% | 7.9% | 10.4% | 13.2% | 14.5% | 16.7% | |
| 2.6% | 6.9% | -66.9% | -106.0% | -229.0% | -100.0% | -557.0% | -39.6% | -53.1% | -12.1% | -261.9% | -16,571.7% | -1,861.1% | -1,623.2% | -36.7% | 44.7% | 4.0% | -1,678.9% | – | -444.7% | -930.9% | -74.6% | 9.1% | 10.9% | 14.2% | 12.2% | 17.8% | 22.0% | 27.2% | 23.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.